Concepts (140)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Anemia, Sickle Cell | 9 | 2024 | 1020 | 2.490 |
Why?
|
Cost-Benefit Analysis | 23 | 2024 | 5388 | 2.220 |
Why?
|
Quality-Adjusted Life Years | 13 | 2024 | 1683 | 1.420 |
Why?
|
Models, Economic | 3 | 2021 | 712 | 0.820 |
Why?
|
Vaginosis, Bacterial | 1 | 2023 | 128 | 0.790 |
Why?
|
Airports | 2 | 2018 | 28 | 0.790 |
Why?
|
Quality of Life | 7 | 2024 | 12788 | 0.780 |
Why?
|
Noise, Transportation | 2 | 2018 | 50 | 0.750 |
Why?
|
Aircraft | 2 | 2018 | 123 | 0.730 |
Why?
|
Early Detection of Cancer | 3 | 2021 | 3089 | 0.670 |
Why?
|
Technology Assessment, Biomedical | 1 | 2020 | 306 | 0.640 |
Why?
|
New York City | 7 | 2019 | 705 | 0.630 |
Why?
|
Biomedical Technology | 1 | 2020 | 220 | 0.630 |
Why?
|
Drug Approval | 1 | 2023 | 742 | 0.570 |
Why?
|
Environment Design | 2 | 2018 | 178 | 0.570 |
Why?
|
Comparative Effectiveness Research | 1 | 2020 | 680 | 0.520 |
Why?
|
Accidents, Traffic | 2 | 2018 | 819 | 0.510 |
Why?
|
Sexually Transmitted Diseases | 1 | 2019 | 623 | 0.450 |
Why?
|
Prostatic Neoplasms | 4 | 2024 | 11059 | 0.440 |
Why?
|
Health Care Costs | 3 | 2023 | 3207 | 0.410 |
Why?
|
Prostate-Specific Antigen | 1 | 2021 | 2471 | 0.390 |
Why?
|
Urbanization | 2 | 2022 | 104 | 0.370 |
Why?
|
Medicare | 4 | 2024 | 6565 | 0.340 |
Why?
|
Markov Chains | 5 | 2018 | 968 | 0.330 |
Why?
|
Depression | 2 | 2019 | 7760 | 0.330 |
Why?
|
Computer Simulation | 2 | 2021 | 6188 | 0.320 |
Why?
|
Wounds and Injuries | 2 | 2018 | 2401 | 0.320 |
Why?
|
Public Health | 2 | 2018 | 2603 | 0.300 |
Why?
|
Research Design | 1 | 2023 | 5983 | 0.300 |
Why?
|
Pharmaceutical Preparations | 4 | 2023 | 1070 | 0.290 |
Why?
|
Mass Screening | 2 | 2021 | 5251 | 0.270 |
Why?
|
United States | 12 | 2024 | 69859 | 0.250 |
Why?
|
Androgen Antagonists | 2 | 2024 | 1376 | 0.240 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2022 | 11524 | 0.230 |
Why?
|
Nonprescription Drugs | 1 | 2022 | 116 | 0.200 |
Why?
|
Humans | 37 | 2024 | 743811 | 0.200 |
Why?
|
Insurance | 1 | 2023 | 111 | 0.200 |
Why?
|
Androstenes | 1 | 2022 | 168 | 0.200 |
Why?
|
Antisickling Agents | 1 | 2021 | 80 | 0.200 |
Why?
|
Hydroxyurea | 1 | 2021 | 289 | 0.180 |
Why?
|
Automobiles | 1 | 2020 | 116 | 0.180 |
Why?
|
Sample Size | 1 | 2023 | 841 | 0.180 |
Why?
|
Budgets | 1 | 2021 | 229 | 0.170 |
Why?
|
Comorbidity | 3 | 2022 | 10380 | 0.170 |
Why?
|
Male | 19 | 2024 | 349776 | 0.160 |
Why?
|
Aged | 12 | 2024 | 163178 | 0.160 |
Why?
|
Drug Costs | 2 | 2022 | 1105 | 0.150 |
Why?
|
Prednisone | 1 | 2022 | 1574 | 0.150 |
Why?
|
Hypertension | 3 | 2023 | 8480 | 0.150 |
Why?
|
Bicycling | 1 | 2018 | 176 | 0.150 |
Why?
|
Health Planning | 1 | 2018 | 237 | 0.150 |
Why?
|
Poverty | 2 | 2019 | 2660 | 0.150 |
Why?
|
Law Enforcement | 1 | 2018 | 109 | 0.140 |
Why?
|
SEER Program | 1 | 2021 | 1507 | 0.140 |
Why?
|
Sensitivity and Specificity | 2 | 2021 | 14714 | 0.140 |
Why?
|
Probability | 1 | 2021 | 2505 | 0.130 |
Why?
|
Health Status Indicators | 1 | 2021 | 970 | 0.130 |
Why?
|
United States Food and Drug Administration | 1 | 2023 | 1582 | 0.130 |
Why?
|
Androgens | 1 | 2022 | 1247 | 0.130 |
Why?
|
Reimbursement Mechanisms | 1 | 2021 | 670 | 0.130 |
Why?
|
Blood Transfusion | 1 | 2021 | 1301 | 0.120 |
Why?
|
Adult | 13 | 2023 | 213889 | 0.120 |
Why?
|
Disasters | 1 | 2020 | 511 | 0.120 |
Why?
|
Point-of-Care Systems | 1 | 2023 | 1177 | 0.120 |
Why?
|
Magnetic Resonance Imaging | 1 | 2021 | 35409 | 0.120 |
Why?
|
Female | 15 | 2023 | 380020 | 0.120 |
Why?
|
Breast Neoplasms | 1 | 2021 | 20827 | 0.110 |
Why?
|
Middle Aged | 11 | 2022 | 213241 | 0.110 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2021 | 1581 | 0.110 |
Why?
|
Antigens, Neoplasm | 1 | 2021 | 1988 | 0.110 |
Why?
|
Psychometrics | 1 | 2022 | 3000 | 0.110 |
Why?
|
Automobile Driving | 1 | 2018 | 430 | 0.110 |
Why?
|
Tissue Plasminogen Activator | 1 | 2019 | 1263 | 0.110 |
Why?
|
Neoplasms | 1 | 2021 | 21675 | 0.110 |
Why?
|
Triage | 1 | 2019 | 977 | 0.100 |
Why?
|
Cross-Sectional Studies | 3 | 2023 | 25032 | 0.100 |
Why?
|
Hypertension, Pulmonary | 1 | 2022 | 1534 | 0.100 |
Why?
|
Forecasting | 1 | 2021 | 2950 | 0.100 |
Why?
|
Receptor, erbB-2 | 1 | 2021 | 2418 | 0.100 |
Why?
|
Adolescent | 5 | 2023 | 85729 | 0.100 |
Why?
|
Arthroplasty, Replacement, Hip | 1 | 2022 | 1462 | 0.100 |
Why?
|
China | 3 | 2023 | 2243 | 0.090 |
Why?
|
Urban Population | 1 | 2018 | 2021 | 0.090 |
Why?
|
Neoplasm Metastasis | 1 | 2021 | 4848 | 0.090 |
Why?
|
Medicaid | 1 | 2023 | 2736 | 0.090 |
Why?
|
Child | 3 | 2022 | 77637 | 0.090 |
Why?
|
Social Support | 1 | 2019 | 2118 | 0.090 |
Why?
|
Residence Characteristics | 1 | 2019 | 2050 | 0.080 |
Why?
|
Fibrinolytic Agents | 1 | 2019 | 2159 | 0.080 |
Why?
|
Decision Support Techniques | 1 | 2019 | 1956 | 0.080 |
Why?
|
Genetic Testing | 1 | 2021 | 3439 | 0.080 |
Why?
|
Health Expenditures | 1 | 2021 | 2348 | 0.080 |
Why?
|
Prevalence | 2 | 2022 | 15211 | 0.080 |
Why?
|
Retrospective Studies | 4 | 2024 | 77410 | 0.080 |
Why?
|
Age Factors | 2 | 2021 | 18355 | 0.070 |
Why?
|
Young Adult | 4 | 2023 | 56392 | 0.070 |
Why?
|
Decision Making | 1 | 2020 | 3887 | 0.070 |
Why?
|
Models, Statistical | 1 | 2021 | 5100 | 0.070 |
Why?
|
Pain | 1 | 2021 | 4987 | 0.070 |
Why?
|
Cohort Studies | 3 | 2023 | 40545 | 0.070 |
Why?
|
Brain Ischemia | 1 | 2019 | 3264 | 0.060 |
Why?
|
Logistic Models | 1 | 2019 | 13404 | 0.060 |
Why?
|
Reproducibility of Results | 1 | 2022 | 19894 | 0.060 |
Why?
|
Models, Theoretical | 3 | 2022 | 3587 | 0.060 |
Why?
|
Infant, Newborn | 1 | 2023 | 25609 | 0.060 |
Why?
|
Algorithms | 1 | 2022 | 13869 | 0.050 |
Why?
|
Primary Health Care | 1 | 2017 | 4556 | 0.050 |
Why?
|
Cardiovascular Diseases | 2 | 2023 | 15142 | 0.040 |
Why?
|
Government | 1 | 2020 | 165 | 0.040 |
Why?
|
Systole | 1 | 2022 | 958 | 0.040 |
Why?
|
Infant | 1 | 2021 | 35122 | 0.040 |
Why?
|
Factor VIII | 1 | 2021 | 347 | 0.040 |
Why?
|
Australia | 1 | 2022 | 1167 | 0.040 |
Why?
|
Risk Factors | 3 | 2022 | 72252 | 0.040 |
Why?
|
Child, Preschool | 1 | 2021 | 40964 | 0.040 |
Why?
|
Rare Diseases | 1 | 2022 | 552 | 0.040 |
Why?
|
Behavior | 1 | 2020 | 559 | 0.040 |
Why?
|
Blood Pressure | 2 | 2023 | 8551 | 0.040 |
Why?
|
Costs and Cost Analysis | 1 | 2022 | 1680 | 0.040 |
Why?
|
Stroke | 1 | 2019 | 9975 | 0.030 |
Why?
|
Aged, 80 and over | 1 | 2021 | 57744 | 0.030 |
Why?
|
Socioeconomic Factors | 2 | 2020 | 7784 | 0.030 |
Why?
|
Fever | 1 | 2022 | 1616 | 0.030 |
Why?
|
Nutrition Surveys | 1 | 2020 | 1660 | 0.030 |
Why?
|
Longevity | 1 | 2020 | 1070 | 0.030 |
Why?
|
Pain, Postoperative | 1 | 2022 | 1642 | 0.030 |
Why?
|
Insurance, Health | 1 | 2022 | 2492 | 0.020 |
Why?
|
Thrombolytic Therapy | 1 | 2019 | 2162 | 0.020 |
Why?
|
Emotions | 1 | 2020 | 2656 | 0.020 |
Why?
|
Rural Population | 1 | 2018 | 2207 | 0.020 |
Why?
|
Chronic Disease | 1 | 2022 | 9139 | 0.020 |
Why?
|
Survival Analysis | 1 | 2020 | 10251 | 0.020 |
Why?
|
Emergency Medical Services | 1 | 2019 | 1917 | 0.020 |
Why?
|
Health Promotion | 1 | 2018 | 2205 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2021 | 7908 | 0.020 |
Why?
|
Body Mass Index | 1 | 2023 | 12718 | 0.020 |
Why?
|
Endovascular Procedures | 1 | 2019 | 1980 | 0.020 |
Why?
|
Sex Factors | 1 | 2018 | 10394 | 0.020 |
Why?
|
Incidence | 1 | 2021 | 20948 | 0.010 |
Why?
|
Diet | 1 | 2020 | 7930 | 0.010 |
Why?
|
Concepts
(140)
Derived automatically from this person's publications.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_